McCormick (MKC) Q1 2026 earnings review
The Mexico Illusion: Massive Headline Growth Masks a Reversal in Volume
McCormick's Q1 2026 results present a massive optical illusion. On the surface, Net Sales surged 16.7% and EPS skyrocketed to $3.77. However, this was overwhelmingly driven by the January 2026 acquisition of a controlling interest in McCormick de Mexico (MdM), which added 12.4% to the top line and triggered an $866.8 million non-cash accounting gain. Underneath the acquisition noise, organic sales decelerated to just 1.2%. More concerningly, the company's defining narrative of 2025—consistent volume-led growth—has abruptly reversed. Total volume/mix turned negative (-0.7%), meaning all organic growth was driven purely by price hikes (+1.9%). On the bright side, margin execution was stellar. Adjusted gross margin expanded 100 bps YoY, proving that the company's cost-saving initiatives (CCI) and surgical pricing are successfully offsetting commodity and tariff pressures. Management reaffirmed their full-year guidance, but the path forward relies heavily on the consumer accepting higher prices without further volume deterioration.
🐂 Bull Case
After suffering 120 bps of gross margin contraction in the back half of 2025 due to tariffs and inflation, Q1 2026 delivered a massive 100 bps expansion in Adjusted Gross Margin to 38.6%. The CCI program is working.
The consolidation of MdM adds immediate scale, contributing 13% to segment sales and providing a structurally accretive boost to operating income margins moving forward.
🐻 Bear Case
Management touted 2025 as a triumph of 'differentiated volume-led growth.' In Q1 2026, volume/mix shrank by 0.7%. Consumers are officially pushing back against the new wave of 'surgical' pricing.
The B2B segment remains weak, posting a 1.0% decline in volume/mix. Softness among large CPG clients and cautious branded food service operators continues to pressure this division.
⚖️ Verdict: ⚪
Neutral. The operational execution on margins is excellent and the MdM acquisition is strategically sound. However, a return to negative volume/mix is a fundamental red flag for a consumer staples company. If volume doesn't stabilize, the top-line algorithm will break.
Key Themes
The End of the Volume-Led Growth Streak
The most critical takeaway from Q1 is the reversing trend in volume. Throughout 2025, McCormick outpaced peers by delivering positive volume. In Q1 2026, Consumer segment volume/mix fell 0.4% and Flavor Solutions fell 1.0%. Management had previously warned of elasticity impacts in Q1 due to newly implemented pricing, but seeing it materialize confirms that the consumer has reached a threshold. To hit FY26 guidance, volume must normalize rapidly.
Margin Masterclass via CCI and Pricing
Adjusted gross profit expanded by a staggering 100 basis points YoY. This is a dramatic and accelerating recovery compared to the heavy margin contraction seen in late 2025. It proves that the Comprehensive Continuous Improvement (CCI) program is successfully offsetting higher commodity costs and the annualized tariff impacts that previously spooked investors.
Surging SG&A from Tech and Marketing Investments
Despite strong gross margins, Adjusted Operating Income margin expansion was muted (+30 bps) because SG&A expenses are climbing. Management is heavily funding the global enterprise resource planning (ERP) system and brand marketing. These investments are necessary, but they represent a structural headwind to bottom-line leverage in 2026.
McCormick de Mexico Changes the Baseline
The consolidation of the remaining 25% of McCormick de Mexico fundamentally alters the P&L. It drove a 13% top-line increase and will be a major driver of the targeted 15-19% constant currency operating income growth for the year. The transition from an equity method investment to full consolidation gives McCormick total control over a highly profitable, market-leading asset in Latin America.
Other KPIs
Up 10% YoY. This strips out the massive $3.22 per share non-cash gain from the MdM remeasurement and $0.11 in special charges (mostly deal integration and inventory step-ups). The core earnings growth is solid and tracks well against the FY26 guidance.
Reversing the deleveraging trend of 2025, total debt spiked by nearly $1 billion sequentially (from $3.99B in Q4 2025 to $4.92B in Q1 2026) to fund the $729.9 million net cash acquisition of McCormick de Mexico. This will drive higher net interest expense throughout FY26.
Guidance
Accelerating dramatically on a reported basis due entirely to the MdM acquisition, which contributes 11-13%. Stripping that out, Organic Sales are guided to grow 1-3%, stable compared to FY25's 2.0% organic growth. Achieving this organic target hinges on volume recovering from the negative Q1 print.
Accelerating significantly from FY25's ~3% growth, again driven by the consolidation of MdM. The base business will also benefit from gross margin recovery via the CCI program and lapping the severe margin contractions of late 2025.
Implies a deceleration in growth (+1% to +4% constant currency) compared to the operating income trajectory. This disconnect is caused by significant below-the-line headwinds: a much higher tax rate (~24% vs 21.5% in 2025) and increased net interest expense from the debt taken on for the MdM deal.
Key Questions
Volume Elasticity Thresholds
With volume/mix turning negative in Q1 alongside a 1.9% price increase, have we reached the ceiling for consumer price tolerance? What specific promotional levers are planned for Q2 to resuscitate volume?
Flavor Solutions Pipeline
Large CPG softness was cited throughout 2025 and continues into Q1 2026. Is this purely an inventory destocking issue, or are these clients structurally losing market share? When do you expect B2B volumes to inflect positively?
ERP Implementation Risks
With elevated SG&A driven by the digital transformation and ERP rollout, what specific operational milestones will dictate when these costs peak and begin to leverage down?